AnaPath Services Acquires Envigo CRS S.A.U. in Barcelona to provide full services in non-clinical safety assessment for chemical and pharmaceutical industries

Thursday, November 21, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

GENEVA, Nov. 21, 2019 /PRNewswire/ -- AnaPath Services GmbH, the Swiss CRO specialized in histopathology, has acquired legacy Envigo CRS S.A.U. a CRO for non-clinical safety assessment on November 5th, 2019.

With this step Envigo CRS was renamed to AnaPath Research S.A.U. Furthermore Jorge Zapatero Lorenzo was appointed the general manager of AnaPath Research. Mr Zapatero has been with the company from 1986 until 2014 in roles of increasing responsibility including general manager.

This merger represents a back integration as both companies worked previously together within  RCC / Harlan Laboratories Spain and Switzerland.

After separating due to a buyer of Harlan in 2013, AnaPath developed into a globally recognized expert CRO in histopathology and toxicology. Common history, personal relationship and shared values will make a quick start and integration as one CRO possible; after implementation of technical upgrades, GLP in vivo studies start January 2020.

This merger enhances AnaPath's capabilities and warranties a quick and clean performance of complete safety assessment packages under one roof. The basis for this statement is given by thorough knowledge about each others skills, previously joint training periods, and organization and performance of study packages. AnaPath Services is well known for its high level scientific approach serving clients with strategies and solutions to overcome developmental hurdles. The merger enables AnaPath to convert its understanding of toxicology into immediate progression of critical milestones within Research & Development.

Cision View original content:http://www.prnewswire.com/news-releases/anapath-services-acquires-envigo-crs-sau-in-barcelona-to-provide-full-services-in-non-clinical-safety-assessment-for-chemical-and-pharmaceutical-industries-300962878.html

SOURCE AnaPath Services GmbH



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store